Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 3 | $10,100,948 |
| Sells | 42 | $18,599,378 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 11 Mar 2025 16:33 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 07 Mar 2025 | Sale | 200 | 30.02 | 6,004 | D |
| 11 Mar 2025 16:32 | EWTX | Edgewise Therapeutics Inc | KOCH KEVIN | President and CEO | 07 Mar 2025 | Sale | 100 | 30 | 3,000 | D |
| 07 Feb 2025 16:38 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 05 Feb 2025 | Sale | 8,015 | 30.0216 | 240,623 | D |
| 07 Feb 2025 16:38 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 06 Feb 2025 | Sale | 1,200 | 30.1275 | 36,153 | D |
| 07 Feb 2025 16:38 | EWTX | Edgewise Therapeutics Inc | KOCH KEVIN | President and CEO | 05 Feb 2025 | Sale | 8,636 | 30.0252 | 259,298 | D |
| 07 Feb 2025 16:38 | EWTX | Edgewise Therapeutics Inc | KOCH KEVIN | President and CEO | 06 Feb 2025 | Sale | 900 | 31.1311 | 28,018 | D |
| 07 Feb 2025 16:37 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 05 Feb 2025 | Sale | 10,000 | 30.03 | 300,300 | D |
| 30 Jan 2025 16:05 | EWTX | Edgewise Therapeutics Inc | DONOVAN JOANNE M. | CMO | 28 Jan 2025 | Sale | 25,000 | 27.6263 | 690,658 | D |
| 31 Dec 2024 17:13 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 30 Dec 2024 | Sale | 100,000 | 27.3747 | 2,737,470 | D |
| 27 Dec 2024 16:30 | EWTX | Edgewise Therapeutics Inc | SEMIGRAN MARC | Chief Development Officer | 24 Dec 2024 | Sale | 27,980 | 29.6607 | 829,906 | D |
| 27 Dec 2024 16:30 | EWTX | Edgewise Therapeutics Inc | SEMIGRAN MARC | Chief Development Officer | 24 Dec 2024 | Sale | 1,729 | 30.0803 | 52,009 | D |
| 24 Sep 2024 20:25 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 20 Sep 2024 | Sale | 815 | 29.5074 | 24,049 | D |
| 24 Sep 2024 20:25 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 20 Sep 2024 | Sale | 74,185 | 28.2544 | 2,096,053 | D |
| 24 Sep 2024 20:25 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 23 Sep 2024 | Sale | 20,922 | 27.6295 | 578,064 | D |
| 24 Sep 2024 20:25 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 20 Sep 2024 | Sale | 50,000 | 28.3702 | 1,418,510 | D |
| 24 Sep 2024 20:24 | EWTX | Edgewise Therapeutics Inc | DONOVAN JOANNE M. | CMO | 20 Sep 2024 | Sale | 7,162 | 28.2886 | 202,603 | D |
| 24 Sep 2024 20:24 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 20 Sep 2024 | Sale | 42,068 | 29.0276 | 1,221,133 | D |
| 24 Sep 2024 20:22 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 20 Sep 2024 | Sale | 50,000 | 28.5477 | 1,427,385 | D |
| 24 Sep 2024 20:22 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 20 Sep 2024 | Sale | 4,064 | 28.5862 | 116,174 | D |
| 24 Sep 2024 20:22 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 20 Sep 2024 | Sale | 24,960 | 28.5862 | 713,512 | D |
| 24 Sep 2024 20:22 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 20 Sep 2024 | Sale | 46,068 | 28.5862 | 1,316,909 | D |
| 03 May 2024 18:31 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 02 May 2024 | Sale | 1,956 | 18.91 | 36,988 | D |
| 03 May 2024 18:30 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 02 May 2024 | Sale | 2,157 | 18.91 | 40,789 | D |
| 03 May 2024 18:29 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 02 May 2024 | Sale | 1,718 | 18.91 | 32,487 | D |
| 03 May 2024 18:28 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 02 May 2024 | Sale | 1,576 | 18.91 | 29,802 | D |
| 03 May 2024 18:27 | EWTX | Edgewise Therapeutics Inc | DONOVAN JOANNE M. | CMO | 02 May 2024 | Sale | 3,682 | 18.91 | 69,627 | D |
| 03 May 2024 18:26 | EWTX | Edgewise Therapeutics Inc | KOCH KEVIN | President and CEO | 02 May 2024 | Sale | 3,152 | 18.91 | 59,604 | D |
| 09 Feb 2024 17:43 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 09 Feb 2024 | Sale | 8,029 | 20.0096 | 160,657 | D |
| 09 Feb 2024 17:43 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 08 Feb 2024 | Sale | 3,813 | 20.0065 | 76,285 | D |
| 09 Feb 2024 17:43 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 07 Feb 2024 | Sale | 17,993 | 20.0002 | 359,864 | D |
| 09 Feb 2024 17:42 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 09 Feb 2024 | Sale | 4,800 | 20.0436 | 96,209 | D |
| 09 Feb 2024 17:42 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 08 Feb 2024 | Sale | 4,600 | 20.0106 | 92,049 | D |
| 09 Feb 2024 17:42 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 07 Feb 2024 | Sale | 600 | 20 | 12,000 | D |
| 25 Jan 2024 16:46 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 23 Jan 2024 | Sale | 90,000 | 15.7751 | 1,419,759 | D |
| 25 Jan 2024 16:32 | EWTX | Edgewise Therapeutics Inc | THOMPSON PETER A. | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
| 25 Jan 2024 16:28 | EWTX | Edgewise Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
| 28 Dec 2023 16:39 | EWTX | Edgewise Therapeutics Inc | FOX JONATHAN C | Director | 26 Dec 2023 | Purchase | 10,857 | 9.2989 | 100,958 | D |
| 28 Dec 2023 16:39 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 27 Dec 2023 | Sale | 8,497 | 10.5 | 89,218 | D |
| 28 Dec 2023 16:38 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 26 Dec 2023 | Sale | 172,585 | 9.3293 | 1,610,097 | D |
| 03 May 2023 18:26 | EWTX | Edgewise Therapeutics Inc | DERAKHSHAN BEHRAD | Chief Business Officer | 02 May 2023 | Sale | 1,747 | 8.9049 | 15,557 | D |
| 03 May 2023 18:26 | EWTX | Edgewise Therapeutics Inc | MOORE JOHN R | General Counsel | 02 May 2023 | Sale | 1,897 | 8.9049 | 16,893 | D |
| 03 May 2023 18:26 | EWTX | Edgewise Therapeutics Inc | CARRUTHERS R MICHAEL | Chief Financial Officer | 02 May 2023 | Sale | 1,336 | 8.9049 | 11,897 | D |
| 03 May 2023 18:26 | EWTX | Edgewise Therapeutics Inc | RUSSELL ALAN J | Chief Scientific Officer | 02 May 2023 | Sale | 1,602 | 8.9049 | 14,266 | D |
| 03 May 2023 18:25 | EWTX | Edgewise Therapeutics Inc | DONOVAN JOANNE M. | CMO | 02 May 2023 | Sale | 3,254 | 8.9049 | 28,977 | D |
| 03 May 2023 18:25 | EWTX | Edgewise Therapeutics Inc | KOCH KEVIN | President and CEO | 02 May 2023 | Sale | 3,203 | 8.9049 | 28,522 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)